Research Article: Safety of dupilumab in Chinese pediatric patients aged 6 months and older: a prospective real-world study
Introduction:
Objective: This study analyzes the occurrence and characteristics of adverse drug reactions (ADRs) of dupilumab in children in a real-world setting. It aims to enhance clinical practice and minimize medication safety risks in pediatric patients.
Read more